Here is what the published work used, so you can see the spread rather than a single number.
Read the list as a whole and the pattern is obvious. The number of sessions tracks what was being treated and how deep the treatment went, not a dose that anyone established.
For comparison, the manufacturer's own operator manual says the typical number of treatments is one to six, repeated every three to six weeks, and that generally three to five sessions are needed at mild to moderate depth settings. That is manufacturer labelling, not a trial result.
A dose-finding study takes the same patients with the same problem, gives different numbers of sessions, and compares. That study has essentially not been done for this treatment.
The nearest thing to it is a 2025 paper that combined pig-skin histology with 30 patients. It found that energy per needle correlated almost exactly with the size of the heat-damaged zone under each needle - a correlation of 0.976 - and that total cumulative energy correlated with measured three-dimensional volume change, at 0.676. It also reported a positive association between the number of sessions and the amount of change. Patients received an average of 1.7 sessions, ranging from one to three.
That is genuinely useful. It says more energy in produces more tissue effect, which is the physical basis for why more sessions might do more. Two things to hold beside it: it was not a randomised comparison of session counts, and two of its four authors were affiliated with a device manufacturer, one of them as chief technology officer.
One other genuine session comparison exists, in a retrospective series of 98 people treated on the neck. The group that had three sessions averaged 73.3 per cent improvement in a neck ageing score at three months and 75.1 per cent at six months. The group that had one session averaged 37.0 per cent and 41.6 per cent. The authors report a clear dose-response. It is retrospective and uncontrolled, and people were not randomly assigned to one group or the other - which means the two groups may have differed in ways beyond how many sessions they had.
This is the part most session-count answers skip.
Acne scars have the strongest evidence base for this device class, and studies of them use three or four sessions. A systematic review of 16 studies covering 481 patients, including six randomised trials, concluded the treatment is likely effective as a standalone therapy for acne scarring - while explicitly saying further randomised trials are needed to establish appropriate treatment parameters. In other words, the best-evidenced use of the technology comes with an admission that the correct dose is unsettled.
Laxity and wrinkles sit on lower-tier evidence with the same three-session convention. Two large systematic reviews report consistent improvement in texture and tightening with mostly mild, transient side effects - but both carry manufacturer conflicts of interest, one with three of five authors employed by or speaking for a device company.
Cellulite and body laxity used a single deeper, subcutaneous treatment. That is technically a different protocol from facial dermal treatment, not a smaller version of it.
Acne scars and laxity are not the same ask. A plan for one is not automatically a plan for the other.
A PubMed search for Morpheus8 returns 16 records, and no randomised controlled trial of the device was found. Several of the papers that do exist sit in industry-sponsored journal supplements, with authors who are paid consultants to the manufacturer.
The published research behind any session count you are quoted was generated on Lutronic Genius and Infini, Jeisys, Pollogen, Lumenis Legend Pro and several unnamed machines. Needle design, insulation, depth range and energy delivery differ between them, and those are exactly the variables that would change how many sessions you need.
This is not an argument that Morpheus8 does not work. It is an argument for knowing what the evidence behind the number is - class evidence, not brand evidence.
Worth stating alongside it: Morpheus8's FDA clearances name no cosmetic use at all. The 2019 clearance reads electrocoagulation and hemostasis - surgical language for sealing tissue and stopping bleeding - and the 2023 update covers procedures where coagulation or contraction of soft tissue or hemostasis is needed. Acne scars, wrinkles and laxity appear in neither. Off-label use is legal and routine, and clearance is about equivalence to an earlier device rather than proof of benefit. It simply means the paperwork is not where the answer to "how many sessions" comes from.
Almost every clinic recommends an annual maintenance session, or one or two a year.
No published evidence supports that interval. None. No study has compared maintenance against no maintenance, or annual against six-monthly.
The reason is structural: the longest properly measured follow-up in this literature is six months after the final session. A small number of studies report twelve-month data, but always in tiny subgroups or, in one case, by telephone satisfaction survey rather than measurement. In the 98-person neck series, the twelve-month data came from six of the 98 people. So the question maintenance is meant to answer - when does the result fade - has not been studied.
The most defensible statement in the literature comes from a critical review of 42 higher-quality studies: dermal remodelling after radiofrequency microneedling is slow and progressive, and continues to improve even six months after treatment. That is a statement about improvement up to six months. It is not a statement about durability at one to three years, and the clinic figure of one to three years has no published source.
Ageing also does not pause. Any claim about how long a result holds is tangled up with continued ageing, and no published study has separated the two.
If you get cold sores, say so when you book - not on the day. Antiviral medicine is started in advance, so it has to be prescribed before the appointment. There is no published data on cold sore reactivation after radiofrequency microneedling specifically; the precaution is carried over from laser resurfacing, where reactivation is well documented and prophylaxis is standard.
Also mention a pacemaker or an implantable defibrillator, and any metal implant near the treatment area. These are labelled contraindications for radiofrequency devices and are precautionary rather than tested - the right people to advise you are your cardiology team.